Literature DB >> 8378248

Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release.

O P Rubino1, R Kowalsky, J Swarbrick.   

Abstract

The degree of cross-linking of albumin microspheres, with and without drug, was assessed using turbidity measurements carried out in the presence of water and the protein denaturant guanidine hydrochloride (GuHCl) at a concentration that disrupted noncovalent bonds while having no effect on covalent bonds. The measurements allowed calculation of a turbidity ratio (TG/TW), expressed as the ratio of the turbidity of albumin microspheres in 6 M GuHCl (TG) divided by that in water (TW). A linear relation existed between TG/TW and the (i) temperature at which the microspheres were prepared, (ii) concentration of the cross-linking agent glutaraldehyde, and (iii) time of exposure to a second cross-linking agent, formaldehyde vapor, three conditions that increase the degree of cross-linking. The turbidity ratio also increased as the concentration of the albumin solution used to prepare the microspheres increased from 25 to 50%. Drug release from the microspheres consisted of an initial, rapid, burst followed by a second, slower, phase. The rates in both release phases were inversely related to the turbidity ratio, suggesting that this parameter has utility as an indicator of the degree of cross-linking in albumin microspheres.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378248     DOI: 10.1023/a:1018979126326

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Entrapment of bioactive compounds within native albumin beads: II. Effects of rate and extent of crosslinking on microbead properties.

Authors:  M T Sheu; M A Moustafa; T D Sokoloski
Journal:  J Parenter Sci Technol       Date:  1986 Nov-Dec

Review 2.  Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents.

Authors:  K J Widder; A E Senyei; D F Ranney
Journal:  Adv Pharmacol Chemother       Date:  1979

3.  Glutaraldehyde: nature of the reagent.

Authors:  A H Korn; S H Feairheller; E M Filachione
Journal:  J Mol Biol       Date:  1972-04-14       Impact factor: 5.469

4.  Preparation of metabolizable radioactive human serum albumin microspheres for studies of the circulation.

Authors:  I Zolle; B A Rhodes; H N Wagner
Journal:  Int J Appl Radiat Isot       Date:  1970-03

5.  Incorporation of water-soluble drugs in albumin microspheres.

Authors:  E Tomlinson; J J Burger
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

Review 6.  Chemical cross-linking: reagents and problems in studies of membrane structure.

Authors:  K Peters; F M Richards
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

7.  Magnetic microspheres: a model system of site specific drug delivery in vivo.

Authors:  K J Widder; A E Senyel; G D Scarpelli
Journal:  Proc Soc Exp Biol Med       Date:  1978-06

8.  Magnetic albumin/protein A immunomicrospheres. I. Preparation, antibody binding capacity and chemical stability.

Authors:  J Kandzia; W Scholz; M J Anderson; W Müller-Ruchholtz
Journal:  J Immunol Methods       Date:  1984-12-14       Impact factor: 2.303

9.  Albumin microspheres as carrier of an inhibitor of leukocyte elastase: potential therapeutic agent for emphysema.

Authors:  R R Martodam; D Y Twumasi; I E Liener; J C Powers; N Nishino; G Krejcarek
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

10.  Albumin magnetic microspheres: a novel carrier for myelin basic protein.

Authors:  H Ovadia; A M Carbone; P Y Paterson
Journal:  J Immunol Methods       Date:  1982-08-27       Impact factor: 2.303

View more
  15 in total

1.  Chemical and swelling evaluations of amino group crosslinking in gelatin and modified gelatin matrices.

Authors:  C M Ofner; W A Bubnis
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

Review 2.  Biopolymeric nanoparticles.

Authors:  Sushmitha Sundar; Joydip Kundu; Subhas C Kundu
Journal:  Sci Technol Adv Mater       Date:  2010-02-26       Impact factor: 8.090

3.  Controlling silk fibroin particle features for drug delivery.

Authors:  Andreas S Lammel; Xiao Hu; Sang-Hyug Park; David L Kaplan; Thomas R Scheibel
Journal:  Biomaterials       Date:  2010-03-09       Impact factor: 12.479

4.  The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation.

Authors:  Mahdi Karimi; Pinar Avci; Rezvan Mobasseri; Michael R Hamblin; Hossein Naderi-Manesh
Journal:  J Nanopart Res       Date:  2013-04-01       Impact factor: 2.253

5.  Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating.

Authors:  Guilin Wang; Kevin Siggers; Sufeng Zhang; Hongxing Jiang; Zhenghe Xu; Ronald F Zernicke; John Matyas; Hasan Uludağ
Journal:  Pharm Res       Date:  2008-08-15       Impact factor: 4.200

6.  Ligand Assisted Stabilization of Fluorescence Nanoparticles; an Insight on the Fluorescence Characteristics, Dispersion Stability and DNA Loading Efficiency of Nanoparticles.

Authors:  Amina Rhouati; Akhtar Hayat; Rupesh K Mishra; Diana Bueno; Shakir Ahmad Shahid; Roberto Muñoz; Jean Louis Marty
Journal:  J Fluoresc       Date:  2016-05-21       Impact factor: 2.217

Review 7.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

8.  Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis.

Authors:  Safaa Sebak; Maryam Mirzaei; Meenakshi Malhotra; Arun Kulamarva; Satya Prakash
Journal:  Int J Nanomedicine       Date:  2010-09-20

9.  Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.

Authors:  Qingyong Li; Chen Liu; Xiuhua Zhao; Yuangang Zu; Ying Wang; Baoyou Zhang; Dongmei Zhao; Qi Zhao; Lin Su; Yang Gao; Baihe Sun
Journal:  Int J Nanomedicine       Date:  2011-02-20

10.  An HPLC method for microanalysis and pharmacokinetics of marine sulfated polysaccharide PSS-loaded poly lactic-co-glycolic acid (PLGA) nanoparticles in rat plasma.

Authors:  Peng-Li Li; Chun-Xia Li; Yi-Ting Xue; Hai-Hua Li; Hong-Bing Liu; Xiao-Xi He; Guang-Li Yu; Hua-Shi Guan
Journal:  Mar Drugs       Date:  2013-04-02       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.